Long-Term Opioid Therapy and Risk of Opioid Overdose by Derived Clinical Indication in North Carolina, 2006-2018.
Supporting Files
-
January 2025
-
Available in CDC Stacks on January 01, 2026, 12:00 AM
File Language:
English
Details
-
Alternative Title:Pharmacoepidemiology and Drug Safety, 2025, v. 34, no. 1: Long-Term Opioid Therapy and Risk of Opioid Overdose by Derived Clinical Indication in North Carolina, 2006-2018.
-
Journal Article:Pharmacoepidemiology and Drug Safety
-
Personal Author:
-
Description:Long-term opioid therapy (LTOT) has been shown to be associated with opioid overdose, but the definition of LTOT varies widely across studies. We use a rigorous LTOT definition to examine risk of opioid overdose by duration of treatment.
Data were from a large private health insurance provider in North Carolina linked to mortality records from 2006-2018. Eligible patients were adults (18-64) newly initiating opioid therapy after a pain diagnosis or surgery. We defined LTOT as ≥ 1 opioid prescription per month totaling ≥ 60 days' supply within 90 days. We used inverse probability (IP)-weighted cumulative incidence functions to estimate three-year risk of opioid overdose and IP-weighted Fine-Gray models to estimate sub-distribution hazard ratios, comparing LTOT to short- to medium-term opioid therapy (SMTOT). We also examined modification by derived indication of acute pain or surgery versus chronic pain.
We identified 491 369 patients, and 1.7% were exposed to LTOT. The three-year risk of opioid overdose was 0.3 percentage points (RD
= 0.003, 95% CI: 0.001, 0.005) higher in LTOT patients compared to patients with SMTOT. The weighted hazard of opioid overdose was 4.4 times as high (HR
4.42, 95% CI 2.41, 8.11) among patients exposed to LTOT versus SMTOT. We did not find meaningful modification by clinical indication for opioid therapy.
Exposure to LTOT was associated with increased risk of opioid overdose in this population of privately insured patients using a rigorous definition of LTOT. These findings confirm the importance of guidelines to minimize duration of opioid therapy whenever possible. -
Content Notes:Author manuscript
-
Subjects:
-
Keywords:
-
Source:Pharmacoepidemiology and Drug Safety, 2025, v. 34, no. 1
-
DOI:
-
ISSN:1053-8569 ; 1099-1557
-
Pubmed ID:39805808
-
Pubmed Central ID:PMC12034376
-
Document Type:
-
Funding:UL1 TR001111/TR/NCATS NIH HHSUnited States/ ; T32 AI007001/AI/NIAID NIH HHSUnited States/ ; National Institute of Allergy and Infectious Diseases/ ; UM1 TR004406/TR/NCATS NIH HHSUnited States/ ; R01 CE003009/CE/NCIPC CDC HHSUnited States/ ; R21 DA046048/DA/NIDA NIH HHSUnited States/ ; CC/CDC HHSUnited States/
-
Genre:
-
Place as Subject:
-
Pages in Document:e70090 (20 pdf pages)
-
Volume:34
-
Issue:1
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:d2d9cf3ec255eff8d1b8afdb080d8e4afb474c76a913ba53cb3cf77766f3d7e12488660e8f6ba76c4d2b736563ff5f6c851e17d0cc6ec45e2cf48c84f3248d3c
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access